223 filings
15F-12B
CLYYF
Celyad Oncology SA
9 Feb 24
Securities registration termination (foreign)
6:07am
6-K
CLYYF
Celyad Oncology SA
17 Jan 24
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
6:33am
6-K
CLYYF
Celyad Oncology SA
21 Dec 23
Publication of a transparency notification received from Fortress Investment Group LLC
6:19am
6-K
CLYYF
Celyad Oncology SA
18 Dec 23
Current report (foreign)
12:29pm
6-K
CLYYF
Celyad Oncology SA
4 Dec 23
Celyad announces management change
1:28pm
6-K
kmz9pus
4 Dec 23
Current report (foreign)
1:26pm
6-K
tllnarpil3z
24 Nov 23
Celyad Oncology reports third quarter 2023 financial
8:54am
6-K
7hb26 xhx7j
21 Nov 23
Publication of a transparency notification received from
4:05pm
6-K
ottyz6xmq 32d4
21 Nov 23
Current report (foreign)
8:06am
6-K
qma9l
15 Nov 23
Information on the Total Number of Voting Rights and Total Number of shares with single voting rights
4:37pm
6-K
tzh32vd7vr9swcmu
27 Oct 23
Current report (foreign)
1:45pm
6-K
r7k5l09nvj44
26 Sep 23
Celyad Oncology Announces the Termination of Its American Depository
6:06am
6-K
jg4v8m v3x8
22 Sep 23
Current report (foreign)
6:06am
6-K
lfqxd qhguo6
18 Sep 23
Publication of a rectified transparency notification received from
6:04am
6-K
vjbvw8qhw1
13 Sep 23
Current report (foreign)
6:29am
6-K
rj90e xlqjds
11 Sep 23
Publication of a transparency notification received
6:21am
6-K
5qlp5v10dg5g1i6n
6 Sep 23
Current report (foreign)
6:04am
6-K
llfpfqlqh5zo
5 Sep 23
Celyad Oncology Reports First Half 2023 Financial
6:12am
6-K
mfx1r etj6
25 Aug 23
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
6:07am
25-NSE
fhwhi8gi1 jmwzvj1d8g
10 Jul 23
Exchange delisting
6:04am